Clinical Trial to Evaluate the Immunogenicity of Chikungunya Vaccine

Condition:   Chikungunya Interventions:   Biological: Inactivated Chikungunya virus vaccine 20 mcg;   Biological: Inactivated Chikungunya virus vaccine 30 mcg;   Biological: Inactivated Chikungunya virus vaccine 10 mcg;   Biological: Placebo Sponsor:   Bharat Biotech International Limited Completed
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials